Strong clinical data, record deal activity and renewed investor confidence are driving the next phase of growth and outsized ...
A weak year for the ASX, a long case for resilience. Fidelity's Sam Heithersay on what the past 12 months does and doesn't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results